11546 | Humans |
6706 | Female |
4507 | Male |
4157 | Middle Aged |
4140 | Adult |
2782 | Aged |
2755 | Lymphedema (etiology) |
2531 | Animals |
2225 | Lymphedema |
1563 | Adolescent |
1365 | Lymphedema (therapy) |
1233 | Child |
1225 | Lymphedema (diagnosis) |
1150 | Lymphedema (surgery) |
1082 | Human |
1052 | Breast Neoplasms (surgery) |
953 | Lymphedema (pathology) |
911 | Lymphedema (complications) |
868 | Aged, 80 and over |
851 | Treatment Outcome |
809 | Leg |
801 | Elephantiasis, Filarial (epidemiology) |
777 | Lymphedema (diagnostic imaging) |
690 | Arm |
681 | Child, Preschool |
666 | Follow-Up Studies |
653 | Lymphedema (physiopathology) |
630 | Lymphography |
626 | Treatment |
615 | Diagnosis, Differential |
581 | Elephantiasis, Filarial (prevention & control) |
563 | Elephantiasis, Filarial (drug therapy) |
548 | Chronic Disease |
521 | Elephantiasis, Filarial (parasitology) |
507 | Retrospective Studies |
504 | Time Factors |
495 | Infant |
488 | Risk Factors |
484 | Young Adult |
470 | Breast Neoplasms (complications) |
460 | Elephantiasis, Filarial (immunology) |
455 | Lymph Node Excision (adverse effects) |
443 | Prevalence |
423 | Mastectomy (adverse effects) |
421 | Lymphedema (prevention & control) |
414 | Syndrome |
412 | Quality of Life |
409 | Breast Neoplasms (pathology) |
398 | Mastectomy |
382 | Lymphatic Metastasis |
380 | Prognosis |
377 | Lymphedema (genetics) |
376 | Lymphedema (epidemiology) |
360 | Lymph Node Excision |
355 | Axilla |
351 | Elephantiasis |
350 | Breast Neoplasms (therapy) |
345 | Wuchereria bancrofti |
341 | Prospective Studies |
338 | Postoperative Complications |
337 | Elephantiasis, Filarial (diagnosis) |
323 | Combined Modality Therapy |
320 | Surveys and Questionnaires |
320 | Complication |
319 | Breast Neoplasms (radiotherapy) |
311 | Elephantiasis, Filarial (transmission) |
308 | Lymphedema (drug therapy) |
307 | Diethylcarbamazine (therapeutic use) |
302 | Neoplasm Staging |
302 | Lymphedema (congenital) |
301 | Mice |
298 | Lymph Nodes (pathology) |
297 | Filaricides (therapeutic use) |
296 | Cardiovascular disease |
295 | Bandages |
294 | Drainage |
292 | Wuchereria bancrofti (isolation & purification) |
289 | Case study |
287 | Lymphatic vessel disease |
279 | Wuchereria bancrofti (immunology) |
278 | Infant, Newborn |
253 | Surgery |
248 | Physical Therapy Modalities |
247 | Lower limb |
245 | Radionuclide Imaging |
231 | Skin Neoplasms (pathology) |
230 | Lymphatic System (surgery) |
221 | Incidence |
216 | Cross-Sectional Studies |
214 | Mammary gland |
209 | Severity of Illness Index |
208 | Disease Models, Animal |
207 | Lymphoscintigraphy |
207 | India (epidemiology) |
205 | Lower Extremity |
204 | Lymphatic System (pathology) |
200 | Methods |
200 | Edema |
198 | Leg (blood supply) |
197 | Antigens, Helminth (immunology) |
196 | Lymphedema (psychology) |
195 | Malignant tumor |
193 | Lymph Node Excision (methods) |
192 | Pressure |
192 | Lymphatic System (physiopathology) |
181 | Skin (pathology) |
181 | Postoperative Complications (etiology) |
179 | Biopsy |
178 | Age Factors |
177 | Sensitivity and Specificity |
177 | Radiotherapy (adverse effects) |
176 | Recurrence |
176 | Dogs |
172 | Elephantiasis (etiology) |
171 | Lymphedema (rehabilitation) |
170 | Tomography, X-Ray Computed |
169 | Veins (surgery) |
169 | Lymphatic System (physiology) |
168 | Edema (etiology) |
166 | Lymph Nodes (surgery) |
165 | Upper limb |
165 | Microsurgery (methods) |
164 | Lymphedema (nursing) |
164 | Elephantiasis, Filarial (pathology) |
164 | Diagnosis |
163 | Lymphatic Vessels (surgery) |
161 | Diethylcarbamazine (administration & dosage) |
160 | Elephantiasis, Filarial (blood) |
160 | Breast cancer |
157 | Elephantiasis, Filarial (complications) |
152 | Magnetic Resonance Imaging |
151 | Radiography |
150 | Reproducibility of Results |
149 | India |
148 | Rats |
148 | Filaricides (administration & dosage) |
145 | Lymphography (methods) |
145 | Brugia (immunology) |
144 | Arm (pathology) |
142 | Extremities |
142 | Disease |
142 | Antigens, Helminth (blood) |
141 | Lymph Nodes (diagnostic imaging) |
140 | Enzyme-Linked Immunosorbent Assay |
138 | Ivermectin (therapeutic use) |
138 | Antibodies, Helminth (blood) |
137 | Ultrasonography |
137 | Skin Transplantation |
137 | Pregnancy |
137 | Lymphedema (metabolism) |
136 | Massage |
134 | Case-Control Studies |
133 | Microsurgery |
132 | Phenotype |
131 | Lymph (physiology) |
131 | Leg (surgery) |
130 | Technique |
130 | Pedigree |
130 | Lymphatic Vessels (pathology) |
128 | Neoplasms (complications) |
126 | Surgical Flaps |
126 | Sentinel Lymph Node Biopsy |
126 | Exercise Therapy |
126 | Elephantiasis (pathology) |
124 | Scrotum |
124 | Microfilariae (isolation & purification) |
124 | Lymphatic system |
123 | Skin |
123 | Leg (pathology) |
122 | Chronic |
121 | Drug Therapy, Combination |
119 | Brugia malayi (immunology) |
118 | Limb |
118 | Insect Vectors (parasitology) |
118 | Hemangiosarcoma (pathology) |
118 | Albendazole (therapeutic use) |
117 | Cohort Studies |
116 | Radiotherapy |
115 | Phlebography |
115 | Breast Neoplasms (psychology) |
114 | Lymphedema (classification) |
114 | Lymph Nodes (transplantation) |
114 | Dermatology |
109 | Patient Education as Topic |
109 | Filariasis (epidemiology) |
109 | Endemic Diseases |
109 | Elephantiasis (diagnosis) |
108 | Pilot Projects |
108 | Immunohistochemistry |
108 | Edema (diagnosis) |
107 | Review |
107 | Postoperative Complications (prevention & control) |
106 | Stockings, Compression |
106 | Risk Assessment |
106 | Postoperative Complications (epidemiology) |
106 | Drainage (methods) |
106 | Anastomosis, Surgical |
105 | Predictive Value of Tests |
104 | Transplantation, Autologous |
104 | Brugia |
103 | Lymphedema (immunology) |
102 | Survivors |
102 | Lymphatic |
102 | Culex (parasitology) |
101 | Mutation |
101 | Elephantiasis (surgery) |
101 | Breast Neoplasms (rehabilitation) |
101 | Anti-Bacterial Agents (therapeutic use) |
101 | Anastomosis, Surgical (methods) |
100 | Sex Factors |
100 | Filariasis (immunology) |
98 | Health Knowledge, Attitudes, Practice |
98 | Elephantiasis (epidemiology) |
98 | Anthelmintics (therapeutic use) |
97 | Carcinoma, Squamous Cell (surgery) |
96 | Wuchereria bancrofti (drug effects) |
96 | Survival Rate |
96 | Microfilariae (immunology) |
94 | Postoperative Complications (therapy) |
94 | Drug Administration Schedule |
94 | Compression Bandages |
93 | Sentinel Lymph Node Biopsy (adverse effects) |
92 | Leg (diagnostic imaging) |
91 | Lymphangiosarcoma (etiology) |
90 | Age Distribution |
89 | Molecular Sequence Data |
88 | Skin disease |
88 | Skin Neoplasms (surgery) |
88 | Lymphangiosarcoma (pathology) |
88 | Immunoglobulin G (blood) |
87 | Uterine Cervical Neoplasms (surgery) |
87 | Neoplasm Recurrence, Local |
87 | Insect Vectors |
86 | Postoperative Care |
86 | Microfilariae |
86 | Lymphatic Vessels (diagnostic imaging) |
85 | Melanoma (surgery) |
85 | Exploration |
85 | Breast Neoplasms (drug therapy) |
84 | Obesity (complications) |
84 | Ivermectin (administration & dosage) |
84 | Acute Disease |
83 | Pain (etiology) |
83 | Genital Diseases, Male (surgery) |
83 | Double-Blind Method |
83 | Chyle |
82 | Postoperative Complications (surgery) |
81 | Skin Neoplasms (etiology) |
81 | Scintigraphy |
81 | Longitudinal Studies |
81 | Edema (therapy) |
81 | Arm (surgery) |
81 | Antigens, Helminth (analysis) |
80 | Upper Extremity |
80 | Scrotum (surgery) |
80 | Global Health |
80 | Gerbillinae |
79 | Skin Neoplasms (complications) |
79 | Randomized Controlled Trials as Topic |
79 | Lymphatic System (anatomy & histology) |
79 | Body Mass Index |
79 | Albendazole (administration & dosage) |
78 | Reconstructive Surgical Procedures (methods) |
78 | Postoperative Complications (diagnosis) |
78 | Morbidity |
78 | Breast Neoplasms (mortality) |
77 | Lymphangiogenesis (physiology) |
77 | Cells, Cultured |
77 | Axilla (surgery) |
76 | Rural Population |
76 | Electric Impedance |
75 | Wound Healing |
75 | Radiotherapy, Adjuvant (adverse effects) |
75 | Mastectomy (methods) |
75 | Disease Progression |
74 | Vulvar Neoplasms (surgery) |
74 | Neoplasm Metastasis |
74 | Endemic Diseases (prevention & control) |
73 | Range of Motion, Articular |
73 | Hemangiosarcoma (etiology) |
73 | Elephantiasis (therapy) |
72 | Radiotherapy, Adjuvant |
72 | Lymphatic System |
72 | Lymph |
72 | Feasibility Studies |
71 | Survival Analysis |
71 | Socioeconomic Factors |
71 | Mastectomy, Segmental |
71 | Fatal Outcome |
71 | Adaptation, Psychological |
70 | Lymphadenectomy |
69 | Models, Biological |
69 | Mice, Inbred C57BL |
69 | Lymphangiogenesis |
69 | Kinesitherapy |
69 | Elephantiasis, Filarial (therapy) |
69 | Culicidae (parasitology) |
69 | Coloring Agents |
69 | Breast Neoplasms (physiopathology) |
68 | Lymphatic System (abnormalities) |
68 | Contrast Media |
68 | Breast Neoplasms (diagnosis) |
67 | Wuchereria bancrofti (genetics) |
67 | Tumor |
67 | Technetium |
67 | Lower Extremity (pathology) |
67 | Hand |
67 | Filariasis (complications) |
67 | Eyelashes (abnormalities) |
66 | Skin Neoplasms (diagnosis) |
66 | Radiotherapy Dosage |
66 | Disease-Free Survival |
66 | Chemotherapy |
66 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
66 | Analysis of Variance |
65 | Rabbits |
65 | Penile Diseases (surgery) |
65 | Patient Compliance |
65 | Obesity, Morbid (complications) |
65 | Lymphedema (chemically induced) |
65 | Exercise |
65 | Association |
64 | Rural Health |
64 | Lymphatic Vessels (physiology) |
64 | Lymphatic Vessels (metabolism) |
64 | Congenital |
64 | Amino Acid Sequence |
64 | Activities of Daily Living |
63 | Radiopharmaceuticals |
63 | Postoperative |
63 | Groin |
63 | Carcinoma |
62 | Wuchereria bancrofti (growth & development) |
62 | United Kingdom |
62 | Indocyanine Green |
62 | Filariasis (drug therapy) |
62 | Chemotherapy, Adjuvant |
62 | Arm (physiopathology) |
62 | Amputation |
61 | Vulvar Neoplasms (pathology) |
61 | Lymph node |
61 | Logistic Models |
61 | Filariasis (diagnosis) |
61 | Ethiopia |
61 | Equipment Design |
61 | Clothing |
60 | Venous Insufficiency (therapy) |
60 | Medical Records |
60 | Coumarins (therapeutic use) |
60 | Breast Neoplasms (diagnostic imaging) |
59 | Vascular Endothelial Growth Factor Receptor-3 (genetics) |
59 | Sentinel Lymph Node Biopsy (methods) |
59 | Self Care |
59 | Mice, Inbred BALB C |
59 | Filariasis (parasitology) |
59 | Diethylcarbamazine (adverse effects) |
58 | Venous Insufficiency (complications) |
58 | Penis |
58 | Lymphatic Diseases (diagnostic imaging) |
58 | Lymphangiosarcoma |
58 | Antibodies, Helminth (immunology) |
57 | United States |
57 | Survivors (psychology) |
57 | Practice Guidelines as Topic |
57 | Microscopy, Electron |
57 | Microfilariae (drug effects) |
57 | Lymphatic Vessels (physiopathology) |
57 | Breast |
57 | Arm (blood supply) |
56 | Sex Distribution |
56 | Medicine |
56 | Filariasis |
56 | Edema (physiopathology) |
56 | Base Sequence |
55 | Epidemiology |
55 | Anopheles (parasitology) |
54 | World Health Organization |
54 | Physical Therapy Modalities (methods) |
54 | Lymphocyte Activation |
54 | Hemangiosarcoma (diagnosis) |
54 | Comorbidity |
54 | Arm (diagnostic imaging) |
53 | Tropical medicine |
53 | Population Surveillance |
53 | Pathology |
53 | Nursing Assessment |
53 | Elephantiasis (complications) |
53 | Carcinoma, Squamous Cell (pathology) |
53 | Angiography |
52 | Uterine Cervical Neoplasms (pathology) |
52 | Upper Extremity (pathology) |
52 | Treatment efficiency |
52 | Scrotum (pathology) |
52 | Pleural Effusion (complications) |
52 | Penis (surgery) |
52 | Palliative Care |
52 | Multivariate Analysis |
52 | Magnetic Resonance Imaging (methods) |
52 | Lymphangiosarcoma (diagnosis) |
52 | Hindlimb |
51 | Quality of life |
51 | Prevention |
51 | Nail Diseases (complications) |
51 | Melanoma (pathology) |
51 | Exercise Therapy (methods) |
51 | Attitude to Health |
50 | Wuchereria bancrofti (physiology) |
50 | Risk factor |
50 | Pathophysiology |
50 | Mosquito Control (methods) |
50 | Lymphedema (blood) |
50 | Lymphatic filariasis |
50 | Lymphatic Diseases (diagnosis) |
50 | Inguinal Canal |
50 | Carcinoma (surgery) |
50 | Breast Neoplasms (epidemiology) |
50 | Angiosarcoma |
49 | Symptomatology |
49 | Neoplasms (therapy) |
49 | Leg Ulcer (etiology) |
49 | Fibrosis |
49 | Clinical Trials as Topic |
49 | Abnormalities, Multiple (genetics) |
48 | Venous Insufficiency (diagnosis) |
48 | Social Support |
48 | Onchocerciasis (drug therapy) |
48 | Mastectomy, Radical |
48 | Lymph Nodes (blood supply) |
48 | Lipectomy |
48 | Elephantiasis, Filarial (physiopathology) |
48 | Elephantiasis, Filarial (diagnostic imaging) |
48 | Anthelmintics (administration & dosage) |
47 | Physiotherapy |
47 | Mastectomy, Radical (adverse effects) |
47 | Genital Neoplasms, Female (surgery) |
47 | Elephantiasis, Filarial (economics) |
47 | Developing Countries |
47 | Cellulitis (etiology) |
46 | T-Lymphocytes (immunology) |
46 | Surgical Flaps (blood supply) |
46 | Regression Analysis |
46 | Preoperative Care |
46 | Onchocerciasis (epidemiology) |
46 | Lymphatic Metastasis (pathology) |
46 | History, 20th Century |
46 | Genotype |
46 | Brugia malayi |
45 | Technetium Tc 99m Sulfur Colloid |
45 | Skin (blood supply) |
45 | Program Evaluation |
45 | Penile Diseases (etiology) |
45 | Onchocerciasis (prevention & control) |
45 | Health Surveys |
45 | Genetic Predisposition to Disease |
45 | Forkhead Transcription Factors (genetics) |
45 | Foot |
45 | Evidence-Based Medicine |
45 | Compression |
45 | Carcinoma, Ductal, Breast (surgery) |
44 | Lymphangioma (pathology) |
44 | Family study |
44 | Erysipelas (complications) |
44 | Endometrial Neoplasms (surgery) |
44 | Elephantiasis, Filarial (psychology) |
44 | Edema (pathology) |
44 | Edema (diagnostic imaging) |
44 | Comparative study |
44 | Brugia malayi (isolation & purification) |
44 | Algorithms |
43 | Uterine Cervical Neoplasms (radiotherapy) |
43 | Thrombophlebitis (complications) |
43 | Technetium Tc 99m Aggregated Albumin |
43 | Signal Transduction |
43 | Sarcoma |
43 | Reoperation |
43 | Postoperative Period |
43 | Melanoma (secondary) |
43 | Lymphatic Diseases (complications) |
43 | Lymphangiogenesis (genetics) |
43 | Filariasis (prevention & control) |
43 | Enzyme-Linked Immunosorbent Assay (methods) |
43 | Cancerology |
43 | Biopsy, Needle |
43 | Antibodies, Helminth (analysis) |
42 | Venous Insufficiency (physiopathology) |
42 | Thigh |
42 | Quality of Life (psychology) |
42 | Patient Care Team |
42 | Neoplasm Invasiveness |
42 | Lymphatic Vessels (embryology) |
42 | Lymphatic Metastasis (diagnosis) |
42 | Lymphangiectasis |
42 | Immunity, Cellular |
42 | Filaricides (pharmacology) |
42 | Ethiopia (epidemiology) |
42 | Endothelial Cells (metabolism) |
42 | Dose-Response Relationship, Drug |
42 | Brugia (isolation & purification) |
42 | Brazil |
42 | Antineoplastic Agents (adverse effects) |